InvestorsHub Logo
Followers 523
Posts 6631
Boards Moderated 1
Alias Born 07/24/2012

Re: None

Monday, 10/08/2012 2:31:39 PM

Monday, October 08, 2012 2:31:39 PM

Post# of 130503
Amarantus BioSciences is interested in partnering opportunities for its product candidates that will allow development of adjunct -products that will address diseases caused by poorly served biological pathways. We intend to generate revenues through collecting up-front and milestone payments as our candidates advance through pre-clinical and clinical development, and royalties upon commercialization.

They are doing just that wink